Current Assets
Derivative assets
Edwards Lifesciences Derivative assets increased by 88.3% to $40.30M in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2024
Last reportedQ4 2024
How to read this metric
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
Detailed definition
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Peer comparison
Standard for large financial institutions with significant capital markets operations.
Metric ID:
fin_derivative_assetsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $21.40M | $40.30M |
| QoQ Change | — | +88.3% |
Range$21.40M – $40.30M
Derivative assets at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's derivative assets?
- Edwards Lifesciences (EW) reported derivative assets of $40.30M in Q1 2026.
- What does derivative assets mean?
- The value of derivative contracts that currently have a positive market value for the firm.